Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2015 1
2016 3
2017 3
2018 2
2019 1
2020 4
2021 2
2022 3
2024 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

18 results

Results by year

Filters applied: . Clear all
Page 1
Ublituximab versus Teriflunomide in Relapsing Multiple Sclerosis.
Steinman L, Fox E, Hartung HP, Alvarez E, Qian P, Wray S, Robertson D, Huang D, Selmaj K, Wynn D, Cutter G, Mok K, Hsu Y, Xu Y, Weiss MS, Bosco JA, Power SA, Lee L, Miskin HP, Cree BAC; ULTIMATE I and ULTIMATE II Investigators. Steinman L, et al. N Engl J Med. 2022 Aug 25;387(8):704-714. doi: 10.1056/NEJMoa2201904. N Engl J Med. 2022. PMID: 36001711 Clinical Trial.
Validation of the Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS) in the Russian Population.
Evdoshenko E, Laskova K, Shumilina M, Nekrashevich E, Andreeva M, Neofidov N, Kalinin I, Nikitchenko D, Rogozina A, Kupaeva A, Bulanov I, Bakirtzis C, Grigoriadis N, Khachanova N, Davydovskaya M, Makshakov G. Evdoshenko E, et al. Among authors: makshakov g. J Int Neuropsychol Soc. 2022 May;28(5):503-510. doi: 10.1017/S1355617721000722. Epub 2021 Jun 16. J Int Neuropsychol Soc. 2022. PMID: 34132190
Neurofilament light chain and oligoclonal bands are prognostic biomarkers in radiologically isolated syndrome.
Matute-Blanch C, Villar LM, Álvarez-Cermeño JC, Rejdak K, Evdoshenko E, Makshakov G, Nazarov V, Lapin S, Midaglia L, Vidal-Jordana A, Drulovic J, García-Merino A, Sánchez-López AJ, Havrdova E, Saiz A, Llufriu S, Alvarez-Lafuente R, Schroeder I, Zettl UK, Galimberti D, Ramió-Torrentà L, Robles R, Quintana E, Hegen H, Deisenhammer F, Río J, Tintoré M, Sánchez A, Montalban X, Comabella M. Matute-Blanch C, et al. Among authors: makshakov g. Brain. 2018 Apr 1;141(4):1085-1093. doi: 10.1093/brain/awy021. Brain. 2018. PMID: 29452342
[Diagnostic value of immunoglobulin free light chains at the debut of multiple sclerosis].
Nazarov VD, Makshakov GS, Mazing AV, Surkova EA, Krasnov VS, Shumilina MV, Totolyan NA, Evdoshenko EP, Lapin SV, Emanuel VL, Skoromets AA. Nazarov VD, et al. Among authors: makshakov gs. Zh Nevrol Psikhiatr Im S S Korsakova. 2017;117(2. Vyp. 2):60-65. doi: 10.17116/jnevro20171172260-65. Zh Nevrol Psikhiatr Im S S Korsakova. 2017. PMID: 28617363 Russian.
Real-world study of efficacy, risk management and reasons for discontinuation of natalizumab for treatment of multiple sclerosis in Russia.
Evdoshenko E, Stepanova A, Shumilina M, Davydovskaya M, Khachanova N, Neofidov N, Kalinin I, Popova E, Dubchenko E, Pozhidaeva N, Volkov A, Sivertseva S, Prilenskaya A, Malkova N, Korobko D, Vergunova I, Shchur S, Makshakov G. Evdoshenko E, et al. Among authors: makshakov g. PLoS One. 2019 May 28;14(5):e0217303. doi: 10.1371/journal.pone.0217303. eCollection 2019. PLoS One. 2019. PMID: 31136608 Free PMC article.
18 results